Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
SHSE:688013's Return-on-Tangible-Equity is ranked better than 76.39% of 758
companies
in the Medical Devices & Instruments industry
Industry Median: 4.08
vs SHSE:688013: 15.19
Touchstone International Medical Science Co (SHSE:688013) Return-on-Tangible-Equity Explanation
Return-on-Tangible-Equity measures the rate of return on the ownership interest (shareholder's tangible equity) of the common stock owners. It measures a firm's efficiency at generating profits from every unit of shareholders' tangible equity (shareholders equity minus intangibles). Return-on-Tangible-Equity shows how well a company uses investment funds to generate earnings growth. Return-on-Tangible-Equitys between 15% and 20% are considered desirable.
Be Aware
Net Income is used.
Because a company can increase its Return-on-Tangible-Equity by having more financial leverage, it is important to watch the leverage ratio when investing in high Return-on-Tangible-Equity companies. Like Return-on-Tangible-Asset, Return-on-Tangible-Equity is calculated with only 12 months data. Fluctuations in company's earnings or business cycles can affect the ratio drastically. It is important to look at the ratio from a long term perspective.
Asset light businesses require very few assets to generate very high earnings. Their Return-on-Tangible-Equitys can be extremely high.
Touchstone International Medical Science Co Return-on-Tangible-Equity Related Terms
Touchstone International Medical Science Co Return-on-Tangible-Equity Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Touchstone International Medical Science Co Return-on-Tangible-Equity Chart
Touchstone International Medical Science Co Annual Data
SHSE:688013 vs ISRG, BDX, MDLN: Return-on-Tangible-Equity Comparison
For the Medical Instruments & Supplies subindustry, Touchstone International Medical Science Co's Return-on-Tangible-Equity, along with its competitors' market caps and Return-on-Tangible-Equity data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Touchstone International Medical Science Co Return-on-Tangible-Equity vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Touchstone International Medical Science Co's Return-on-Tangible-Equity distribution charts can be found below:
* The bar in red indicates where Touchstone International Medical Science Co's Return-on-Tangible-Equity falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
In the calculation of annual Return-on-Tangible-Equity, the net income of the last fiscal year and the average total shareholder tangible equity over the fiscal year are used. In calculating the quarterly data,
the net income data used here is four times the quarterly (Mar. 2026) net income data.
Return-on-Tangible-Equity is displayed in the 10-year financial page.
What does a Return-on-Tangible-Equity of 7.31% mean?
Touchstone International Medical Science Co (SHSE:688013) has a Return-on-Tangible-Equity of 7.31% as of Mar. 2026. Return on tangible equity is the ratio of current-period net income to average two-period tangible equity. View historical data on Touchstone International Medical Science Co and its competitors. This is 41% below median its historical median of 12.34. Over the past decade, Touchstone International Medical Science Co's Return-on-Tangible-Equity has ranged from 8.52 to 45.86. According to the industry distribution chart, Touchstone International Medical Science Co ranks #179 out of 758 companies in the Medical Devices & Instruments industry, placing it in the top 23.6%.
Is Touchstone International Medical Science Co's Return-on-Tangible-Equity too high?
Touchstone International Medical Science Co's current Return-on-Tangible-Equity of 7.31% is 41% below median its 10-year median of 12.34. Over the past 10 years, this metric has ranged from a low of 8.52 to a high of 45.86. The Medical Devices & Instruments industry median Return-on-Tangible-Equity is 4.08. Touchstone International Medical Science Co's value of 7.31% is 79.2% above this industry median. Based on the distribution chart, Touchstone International Medical Science Co ranks #179 out of 758 companies in the Medical Devices & Instruments industry, which is in the top quartile — a strong position relative to peers. Overall, Touchstone International Medical Science Co has a GF Score™ of 83/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Touchstone International Medical Science Co's Return-on-Tangible-Equity compare to ISRG and BDX?
According to the Medical Devices & Instruments industry distribution chart, Touchstone International Medical Science Co ranks #179 out of 758 companies for Return-on-Tangible-Equity. This places Touchstone International Medical Science Co in the top 24% of its industry — outperforming the majority of peers. The industry median Return-on-Tangible-Equity is 4.08. Touchstone International Medical Science Co's value of 7.31% is 79.2% above this benchmark. Historically, Touchstone International Medical Science Co's own Return-on-Tangible-Equity has ranged from 8.52 to 45.86 over the past decade. While the company's 10-year median is 12.34 vs. the industry median of 4.08, Touchstone International Medical Science Co has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Return-on-Tangible-Equity for a Medical Devices & Instruments company?
The median Return-on-Tangible-Equity among Medical Devices & Instruments companies is 4.08, based on 758 companies in the industry. Companies in the top quartile (top 25%) have a Return-on-Tangible-Equity significantly above this median, while those in the bottom quartile fall well below. However, Return-on-Tangible-Equity should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Touchstone International Medical Science Co's current Return-on-Tangible-Equity of 7.31% is 79.2% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Return-on-Tangible-Equity mean?
A high Return-on-Tangible-Equity can signal that a stock is expensive relative to its fundamentals. Return on tangible equity is the ratio of current-period net income to average two-period tangible equity. View historical data on Touchstone International Medical Science Co and its competitors. For the Medical Devices & Instruments industry, the median Return-on-Tangible-Equity is 4.08 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Touchstone International Medical Science Co's current Return-on-Tangible-Equity is 7.31%, which is 41% below median its own 10-year median of 12.34. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Touchstone International Medical Science Co stock overvalued right now?
Based on GuruFocus' analysis, Touchstone International Medical Science Co (SHSE:688013) is currently considered Modestly Undervalued. The stock's GF Value™ is ¥28.56, compared to a current price of ¥22.89 — trading 19.9% below its estimated fair value. The current Return-on-Tangible-Equity is 7.31%, which is 41% below median its 10-year median of 12.34 and 79.2% above the Medical Devices & Instruments industry median of 4.08. Touchstone International Medical Science Co's overall GF Score™ is 83/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Return-on-Tangible-Equity calculated?
Return-on-Tangible-Equity is calculated from a company's financial statements. For Touchstone International Medical Science Co (SHSE:688013), the current Return-on-Tangible-Equity is 7.31% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Touchstone International Medical Science Co (SHSE:688013) Overvalued in 2026?
Based on GuruFocus' analysis, Touchstone International Medical Science Co stock appears to be undervalued.
The current stock price of ¥22.89 is trading 19.9% below its estimated GF Value™ of ¥28.56.
GuruFocus considers Touchstone International Medical Science Co to be Modestly Undervalued.
Key valuation signals for SHSE:688013:
Return-on-Tangible-Equity: 7.31% (41% below median its 10-year median of 12.34)
GF Value™: ¥28.56 vs. price of ¥22.89 (19.9% below fair value)
Industry Position: 79.2% above the Medical Devices & Instruments median (#179 of 758)
No single metric tells the full story. See the SHSE:688013 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Touchstone International Medical Science Co Business Description
Touchstone International Medical Science Co Ltd is specialized in the development of surgical staplers that enhance clinical performance, minimise risk and improve patient outcomes. The company's products include Auto Purse String Clamp for Single Use (APS); Intraluminal Stapler for Single Use (CSC&ECSC); Endoscopic Linear Cutter and Single Use Loading Unit (ELC&ELCC); Intraluminal Stapler for Single Use (KOL); Linear Cutter and Reloads (LC&LCC); Linear Stapler and Reloads (LS&LSC); PPH Stapler and Purse Sets for Single Use (PPH); Tissue - Selecting Therapy Stapler (TST33); Tissue - Selecting Therapy Stapler (TST36); and Tissue - Selecting Therapy Stapler (Proctology Examination Kit).
83GF Score
Get the complete analysis for SHSE:688013
Return-on-Tangible-Equity is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
SHSE:688013 has been successfully added to your 
